Search - tctmd.com

Displaying 1 - 20 of 181

Sort: Relevancy | Date

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Daily News

Societies Propose Volume, Proficiency Needs for Mitral Interventions

Todd Neale

December 17, 2019

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News PCR London Valves 2019

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

Michael O'Riordan

November 22, 2019

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Conference News PCR London Valves 2019

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

Michael O'Riordan

November 17, 2019

Podcast TCTMD Talking Points

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

November 06, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

Presentation TCT 2019

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Suzanne Baron

September 29, 2019

Presentation TCT 2019

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

Presenter: Georg Nickenig

September 28, 2019

Presentation TCT 2019

TRUE Registry: A New Prognostic Risk Score for Risk Stratification of Patients With Severe Tricuspid Regurgitation

Presenter: Alexander Lauten

September 28, 2019

Presentation TCT 2019

Mitral Regurgitation as a Target for Heart Failure, and the Relevance of Proportionate vs. Disproportionate MR

Presenter: Susan Joseph

September 28, 2019

Presentation TCT 2019

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Presenter: Linda Gillam

September 28, 2019

Presentation TCT 2019

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Presentation TCT 2019

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Presenter: Howard Herrmann

September 28, 2019

Advertisement

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Societies Propose Volume, Proficiency Needs for Mitral Interventions

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Routine Anticoagulation Seems Warranted After TMVR: Review

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Real-world Data Show MitraClip Benefit in COAPT-Ineligible Patients

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

TRILUMINATE Trial: 6-Month Outcomes of Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation

TRUE Registry: A New Prognostic Risk Score for Risk Stratification of Patients With Severe Tricuspid Regurgitation

Mitral Regurgitation as a Target for Heart Failure, and the Relevance of Proportionate vs. Disproportionate MR

State-of-the-Art Medical Therapy for Treatment of Tricuspid Regurgitation and Its Effect on Prognosis

Case Resolution: How We Treated Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Case Introduction: Moderate Aortic Stenosis and Severe Secondary Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content